Saroglitazar for the treatment of NASH: the PPAR story goes on!
Sign Up to like & getrecommendations! Published in 2021 at "Hepatology"
DOI: 10.1002/hep.32024
Abstract: Despite intensive research, no drug has to date been approved for the management of NAFLD, and many clinical trials have failed, including some recent large phase 3 trials. This has in part to do with… read more here.
Keywords: saroglitazar treatment; treatment nash; story goes; nash ppar ... See more keywords
Icosabutate: targeting metabolic and inflammatory pathways for the treatment of NASH
Sign Up to like & getrecommendations! Published in 2022 at "Expert Opinion on Investigational Drugs"
DOI: 10.1080/13543784.2022.2159804
Abstract: ABSTRACT Introduction Via pleiotropic targeting of membrane and nuclear fatty acid receptors regulating key metabolic and inflammatory pathways in the liver, long-chain omega-3 fatty acids could offer a unique therapeutic approach for the treatment of… read more here.
Keywords: treatment nash; metabolic inflammatory; inflammatory pathways; inflammatory ... See more keywords